GLAXOSMITHKLINE PHARMA A/S: Financial statements 2018
CVR: 27394019
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
GLAXOSMITHKLINE PHARMA A/S (CVR 27394019) has filed annual accounts for 2018. In 2018, the company reported revenue of DKK 413,846,000 and a net result of DKK 17,523,000 compared with DKK 9,597,000 the year before. That is a decrease of 3.1% compared with the year before. The profit margin was 4.2%. Equity in the 2018 report amounted to DKK 39,427,000. The solvency ratio was 17%. The company had 80 employees in the financial year.
- Revenue
- DKK 413,846,000
- Gross Profit
- DKK 116,334,000
- Profit/Loss
- DKK 17,523,000
- Equity
- DKK 39,427,000
- Total Assets
- DKK 231,746,000
- Employees
- 80
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | 413.8 mio. | 116.3 mio. | 17.5 mio. | 39.4 mio. | 80 |
| 2017 | 426.9 mio. | 124.4 mio. | 9.6 mio. | 35.4 mio. | 87 |
| 2016 | 366.5 mio. | 81.8 mio. | 1.9 mio. | 25.8 mio. | 92 |
| 2015 | 338.9 mio. | 111.7 mio. | 3.7 mio. | 147.9 mio. | 87 |
| 2014 | 371.5 mio. | 119.2 mio. | 11.8 mio. | 144.3 mio. | 92 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
As of October 30, 2018, David Mattheus Fredericus Rademakers has joined the board of directors of GLAXOSMITHKLINE PHARMA A/S.
As of October 30, 2018, Saskia Fontein has left the board of directors of GLAXOSMITHKLINE PHARMA A/S.
As of October 30, 2018, David Mattheus Fredericus Rademakers is registered as adm. dir. of GLAXOSMITHKLINE PHARMA A/S.
As of October 30, 2018, Saskia Fontein has stepped down as adm. dir. of GLAXOSMITHKLINE PHARMA A/S.
GLAXOSMITHKLINE PHARMA A/S has published its annual report for 2017. Revenue came to DKK 426,868,000, and the net result was DKK 9,597,000.
As of June 15, 2018, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of GLAXOSMITHKLINE PHARMA A/S.
As of June 15, 2018, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of GLAXOSMITHKLINE PHARMA A/S.
As of June 15, 2018, Neale Andrew Belson has joined the board of directors of GLAXOSMITHKLINE PHARMA A/S.
As of June 15, 2018, Josephine Yang Comiskey has left the board of directors of GLAXOSMITHKLINE PHARMA A/S.
About GLAXOSMITHKLINE PHARMA A/S
GLAXOSMITHKLINE PHARMA A/S is a Danish company of the type Aktieselskab based in Vallensbæk Strand, founded in 1968. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named GLAXO DANMARK A/S and GLAXO WELLCOME A/S. The management consists of Diederik Maarten Eijsvogel. The board consists of Luciano Alves de Andrade (chair), Alastair William Jones, Diederik Maarten Eijsvogel and Helle Ann Hellberg. The company is owned by Setfirst Limited. The company has 83 employees (2026). In 2025, the company reported revenue of DKK 580,769,000 and a net result of DKK 13,123,000 compared with DKK 12,240,000 the year before. Equity in the 2025 report amounted to DKK 39,017,000.